Document Detail


JAK2 V617F mutation is associated with 5q- syndrome in Chinese.
MedLine Citation:
PMID:  19562618     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
JAK2 V617F mutation is mostly seen in BCR-ABLI negative myeloproliferative neoplasms. Among other myeloid neoplasms, it occurs with remarkably high frequency in refractory anemia with ring sideroblasts associated with marked thrombocytosis, a group of myeloid neoplasms with both dysplastic and proliferative features. It has also been reported in occasional cases of myelodysplastic syndrome with isolated del(5q), often with a diagnosis of refractory cytopenia with multilineage dysplasia. We performed a retrospective analysis of JAK2 V617F mutation in Chinese patients with myeloid neoplasms and isolated del(5q), and were able to demonstrate the frequent occurrence of JAK2 V617F mutation in 5q- syndrome.
Authors:
K F Wong; W S Wong; Lisa L P Siu; T C Lau; N P Chan
Related Documents :
12186468 - A novel fibroblast growth factor receptor 2 mutation in crouzon syndrome associated wit...
19458618 - Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor ...
17101338 - Prophylactic bilateral salpingo-oopherectomy in a 17-year-old with frasier syndrome rev...
1906048 - The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulp...
17487218 - Marfan syndrome: clinical diagnosis and management.
12186468 - A novel fibroblast growth factor receptor 2 mutation in crouzon syndrome associated wit...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  50     ISSN:  1029-2403     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-11-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  England    
Other Details:
Languages:  eng     Pagination:  1333-5     Citation Subset:  IM    
Affiliation:
Department of Pathology, Queen Elizabeth Hospital, Hong Kong SAR, China. kfwong@ha.org.hk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variable Contribution of Monoclonal Antibodies to ADCC in patients with chronic lymphocytic leukemia...
Next Document:  Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younge...